Liquid Biopsy and Circulating Biomarker Analysis
“Unlocking Non-Invasive Cancer Detection Through Liquid Biopsy”
Online/ e-LMS
Self Paced
Moderate
4 Weeks
About
Liquid biopsy is an emerging technique revolutionizing cancer diagnostics by providing a non-invasive method for detecting and analyzing circulating biomarkers such as circulating tumor cells (CTCs) and circulating nucleic acids (cfDNA, ctDNA). This program offers an in-depth exploration of the principles behind liquid biopsy, including the various technologies used for biomarker isolation, quantification, and analysis. Participants will also explore the clinical relevance of liquid biopsy in cancer detection, treatment monitoring, and personalized medicine.
The program combines theoretical knowledge with practical skills, providing participants with hands-on experience in liquid biopsy technologies, from sample collection and processing to data analysis. The course also covers the regulatory and ethical considerations necessary for implementing liquid biopsy in clinical practice, offering a comprehensive view of how circulating biomarker analysis can significantly impact cancer treatment and patient outcomes.
Aim
The program aims to equip participants with advanced knowledge in liquid biopsy techniques and circulating biomarker analysis for non-invasive cancer detection and monitoring. The course focuses on the identification, isolation, and characterization of circulating tumor cells (CTCs) and circulating nucleic acids (cfDNA, ctDNA) for early diagnosis, prognosis, and therapeutic monitoring.
Program Objectives
- Understand the fundamentals of liquid biopsy and circulating biomarker analysis.
- Gain proficiency in the techniques for isolating and characterizing circulating biomarkers.
- Explore the clinical applications of liquid biopsy in cancer detection and monitoring.
- Evaluate the current technologies used for circulating tumor cell and nucleic acid detection.
- Analyze case studies and clinical trial data related to liquid biopsy and its impact on personalized medicine.
Program Structure
Week 1: Introduction to Liquid Biopsy and Circulating Biomarkers
- Overview of non-invasive diagnostic techniques
- Clinical relevance of circulating biomarkers
- Benefits and limitations of liquid biopsy in modern medicine
Week 2: Technologies for Circulating Tumor Cell (CTC) and cfDNA Analysis
- Techniques for isolating and characterizing circulating tumor cells (CTCs) and cell-free DNA (cfDNA)
- Advances in biomarker detection technologies
- Practical demonstrations on sample processing
Week 3: Applications in Cancer Detection and Monitoring
- Case studies on liquid biopsy in early cancer detection and prognosis
- Monitoring therapy effectiveness through liquid biopsy
- Comparative analysis of traditional vs. liquid biopsy approaches
Week 4: Clinical Trial Data, Ethical Considerations, and Practical Workshop
- Review of clinical trial data on liquid biopsy applications
- Discussion on regulatory guidelines and patient privacy in diagnostics
- Hands-on training in liquid biopsy techniques and data analysis
Participant’s Eligibility
- Undergraduate degree in Life Sciences, Biotechnology, or Biomedical Engineering.
- Professionals in clinical diagnostics, cancer research, or molecular biology.
- Researchers and technologists in oncology and biomarker discovery.
Program Outcomes
- Mastery of liquid biopsy techniques and circulating biomarker analysis.
- Ability to perform non-invasive cancer detection using advanced molecular technologies.
- Understanding of clinical and regulatory aspects of liquid biopsy in oncology.
- Practical experience with liquid biopsy technologies such as cfDNA and CTC analysis.
- Knowledge of how circulating biomarkers contribute to personalized cancer therapies.
Fee Structure
Standard Fee: INR 4,998 USD 110
Discounted Fee: INR 2499 USD 55
We are excited to announce that we now accept payments in over 20 global currencies, in addition to USD. Check out our list to see if your preferred currency is supported. Enjoy the convenience and flexibility of paying in your local currency!
List of CurrenciesBatches
Key Takeaways
Program Assessment
Certification to this program will be based on the evaluation of following assignment (s)/ examinations:
Exam | Weightage |
---|---|
Mid Term Assignments | 50 % |
Project Report Submission (Includes Mandatory Paper Publication) | 50 % |
To study the printed/online course material, submit and clear, the mid term assignments, project work/research study (in completion of project work/research study, a final report must be submitted) and the online examination, you are allotted a 1-month period. You will be awarded a certificate, only after successful completion/ and clearance of all the aforesaid assignment(s) and examinations.
Program Deliverables
- Access to e-LMS
- Real Time Project for Dissertation
- Project Guidance
- Paper Publication Opportunity
- Self Assessment
- Final Examination
- e-Certification
- e-Marksheet
Future Career Prospects
- Cancer Research Scientist
- Molecular Diagnostics Specialist
- Clinical Laboratory Technologist
- Biomarker Discovery Scientist
- Pharmaceutical Researcher in Oncology
- Clinical Trial Coordinator
Job Opportunities
- Cancer research institutes
- Clinical diagnostic laboratories
- Pharmaceutical and biotech companies
- Hospitals and oncology centers
- Academic research institutions
- Personalized medicine companies
Enter the Hall of Fame!
Take your research to the next level!
Achieve excellence and solidify your reputation among the elite!
Related Courses
Next-Generation Wireless …
Wearable Biosensors for …
Digital Pathology and …
Food Personalization through …
Recent Feedbacks In Other Workshops
Good
Thanks